Kevin Wang is listed as a director on 2 SEC Form D filings by 1 issuer between May 2025 and Mar 2026: Ascellus Health, Inc. (Miami, FL — other health care — 2025–2026; $8M reported sold to 11 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jeff Williams (2 shared filings), Joseph Holtschlag (2 shared filings), Liam Donohue (2 shared filings), Martha Temple (2 shared filings) and Steven G Chrust (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Kevin. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Kevin Wang and found 6 differences: Offering amount changed between filings; Same name, different state: "Kevin Wang" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.